Follow-up Care After Treatment for Endometrial Cancer

This study has been completed.
Sponsor:
Collaborator:
Ottawa Regional Cancer Centre
Information provided by (Responsible Party):
Ottawa Hospital Research Institute
ClinicalTrials.gov Identifier:
NCT00750672
First received: September 9, 2008
Last updated: July 11, 2012
Last verified: July 2012
  Purpose

The purposes of this study are to examine the needs (symptoms, support, information) and satisfaction of women during follow-up in the community after completing treatment for endometrial cancer. This information will be collected from the perspective of the women themselves, their primary care providers (family physician or gynecologist) and the health care providers (oncologist, nurses, social worker, psychologist) at the cancer centre.


Condition
Endometrial Neoplasm

Study Type: Observational
Study Design: Observational Model: Ecologic or Community
Time Perspective: Retrospective
Official Title: Follow-up After Primary Therapy for Endometrial Cancer; Implementation of a Cancer Care Ontario Guideline: A Pilot Evaluation Study.

Resource links provided by NLM:


Further study details as provided by Ottawa Hospital Research Institute:

Primary Outcome Measures:
  • Qualitative description of participants perception [ Time Frame: after 6 month ] [ Designated as safety issue: No ]

Enrollment: 20
Study Start Date: August 2008
Study Completion Date: February 2010
Primary Completion Date: September 2009 (Final data collection date for primary outcome measure)
Detailed Description:

Research Question How has this transfer in follow-up care impacted performance indicators?

  • Volume of follow-up care transferred
  • Percentage of women, who have required a re-entry consultation
  • Fiscal implication of this transfer of follow-up care

Patient stakeholders:

  • What are women's perceptions of the transition of follow-up care?
  • What are women's supportive care needs during the transition of follow-up care and ongoing needs?

Primary Care Practitioner stakeholders:

  • What are the primary care practitioners' perceptions of the process of transition of follow-up care?
  • What are the primary care practitioners' educational needs?
  • What are the primary care practitioners' perceptions of the process of re-entry for in women with suspected recurrence?

Tertiary Centre: Health care providers stakeholders

o What are the perceptions of tertiary health care providers about the transition of follow-up care?

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

The study will employ a convenience sample of women with endometrial cancer treated at the Ottawa Hospital Cancer Centre who have been discharged from follow-up after September 2005. Women will be identified from the Cancer Centre health records. The primary care providers will also be identified by health records as provided by the endometrial cancer patient when they registered with the TOHCC.

Criteria

Inclusion Criteria:

  • Participants- women diagnosed with endometrial cancer:

    • 18 years of age or older.
    • speak English or French
    • who have been treated (surgery and/or radiation therapy) at TOH.
    • who have been discharged from follow-up in the cancer centre in the past 6 months.
  • Participants-primary care provider practitioner:

    • providing follow-up care to at least one woman with endometrial cancer
  • Participants- health care providers at the tertiary centre :

    • physicians, nurses or allied health care providers whose primary responsibility are to provide care to women with gynecological cancer.

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00750672

Locations
Canada, Ontario
The Ottawa Hospital
Ottawa, Ontario, Canada, K1H 8L6
Sponsors and Collaborators
Ottawa Hospital Research Institute
Ottawa Regional Cancer Centre
  More Information

No publications provided

Responsible Party: Ottawa Hospital Research Institute
ClinicalTrials.gov Identifier: NCT00750672     History of Changes
Other Study ID Numbers: OHRI 2008-361, 2008361-01H for OHREB
Study First Received: September 9, 2008
Last Updated: July 11, 2012
Health Authority: Canada: Ethics Review Committee

Keywords provided by Ottawa Hospital Research Institute:
Endometrial neoplasia
Follow-up care
survivorship
Primary care provider

Additional relevant MeSH terms:
Neoplasms
Endometrial Neoplasms
Uterine Neoplasms
Genital Neoplasms, Female
Urogenital Neoplasms
Neoplasms by Site
Uterine Diseases
Genital Diseases, Female

ClinicalTrials.gov processed this record on July 20, 2014